BIOMERICA INC Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
BIOMERICA INC (BMRA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $928.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-08-31
- BIOMERICA INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2026 was $928.00K, a 32.70% decline from fiscal 2025.
- BIOMERICA INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $1.38M, a 3.43% decline from fiscal 2024.
- BIOMERICA INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $1.43M, a 27.62% decline from fiscal 2023.
- BIOMERICA INC valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $1.97M, a 85.61% increase from fiscal 2022.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2026-05-31 | $928.00K 10-K · filed 2026-08-31 | |
| 2025-05-31 | $1.38M 10-K · filed 2026-08-31 | |
| 2024-05-31 | $1.43M 10-K · filed 2025-08-29 | $1.43M 10-K · filed 2024-08-28 |
| 2023-05-31 | $1.97M 10-K · filed 2024-08-28 | |
| 2022-05-31 | $1.06M 10-K · filed 2023-08-25 | |
| 2021-05-31 | $2.29M 10-K · filed 2022-08-29 | $2.10M 10-K · filed 2021-08-27 |
| 2020-05-31 | $1.15M 10-K/A · filed 2021-10-14 | $716.00K 10-K · filed 2020-08-31 |
| 2019-05-31 | $900.00K 10-K · filed 2020-08-31 | |
| 2018-05-31 | $114.00K 10-K · filed 2019-08-29 | |
| 2017-05-31 | $397.00K 10-K · filed 2018-08-29 | |
| 2016-05-31 | $1.04M 10-K · filed 2017-08-29 | |
| 2015-05-31 | $0.00 10-K · filed 2016-08-29 | |
| 2014-05-31 | $0.00 10-K · filed 2014-08-29 | |
| 2013-05-31 | -$280.00K 10-K · filed 2014-08-29 | |
| 2012-05-31 | -$231.00K 10-K · filed 2013-08-29 | $231.00K 10-K · filed 2012-08-29 |
| 2011-05-31 | $11.00K 10-K · filed 2012-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |